After adjustment for age, sex, obesity, DM, HTN, DL, elevated hs‐CRP level, and IR, this quantitative association between muscle strength and the prevalence of NAFLD remained significant (Model 4 in Table3). The gene discussed is MAP3K14; the disease is metabolic dysfunction-associated steatotic liver disease.